Dr Markenson is Professor of Clinical Medicine, Joan and Sanford Weill Medical College of Cornell University. He is also an attending Physician at the Hospital for Special Surgery, the New York Hospital in New York, and Memorial Sloan-Kettering Cancer Center.
Dr Markenson received his MD from the State University of New York, Downstate Medical Center, Brooklyn, and completed his internship at Kings County, at the same institution. He was a Medical Officer for the National Institutes of Health, Division of Biologics Laboratory of Viral Immunology, in Bethesda, MD, and completed his residency at Cornell University Medical Center, The New York Hospital. He also completed a fellowship in Rheumatology at the Hospital for Special Surgery, NY.
Dr Markenson is a member of many boards and societies, including the American Association of Immunology, the American College of Physicians, the New York Academy of Medicine, the American Occupational Medical Association, the American College of Rheumatology, the New York Academy of Science, the American Society of Microbiology, the American Federation for Clinical Research, and the Society for Experimental Medicine and Biology. He has received many awards and honors, including being designated as a Diplomate for the American Board of Internal Medicine and the American Board of Internal Medicine Subspecialty Board of Rheumatology. He has also been named a Lupus Erythematosus Foundation Fellow and elected a Master of the American College of Rheumatology.
Dr Markenson has had articles published in a number of scientific journals and his areas of research interest include immunology, microbiology, occupational medicine, and lupus.
Crystalline Disease (Gout and pseudo gout)
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medical College
Attending Physician, Department of Medicine, Memorial Sloan-Kettering Cancer Center
American Association of Immunology
American College of Physicians
American College of Rheumatology
American Federation for Clinical Research
American Medical Association
American Occupational Medical Association
American Society for Microbiology
National Psoriasis Foundation
New York Academy of Medicine
New York Academy of Science
Society for Experimental Medicine & Biology
The Henry Kunkel Society
Castle Connolly Top Doctors in New York Metro Area, 2002-2019, 2021, 2022
New York Magazine Top Doctors, 2021, 2022
Lupus Erythematosus Foundation Fellow, 1975-1976
Diplomate, American Board of Internal Medicine, 1976
Diplomate, American Board of Internal Medicine, 1978
Subspecialty Board of Rheumatology, 1978
Master American College of Rheumatology, 2011
MD, State University of New York-Downstate Medical Center, New York, 1970
Masters of Science - Physiology and Biochemistry, Rutgers University, New Jersey, 1966
The New York Hospital, Weill Cornell Medical College - Internal Medicine
Sattui SE, Markenson JA. Arthritis Accompanying Endocrine and Metabolic Disorders: Firestein and Kelley’s Textbook of Rheumatology. 2021 Chapter 129 2149-2160
Brostoff SW, Carlo DJ, Dively, et al: Results of a Phase II Rheumatoid Arthritis Clinical Trial Using T-Cell Receptor Peptides. In Advances in Osteoarthritis. Eds. S. Tanka, C. Hamanishi. Tokyo: Springer-Verlag, 1999, pp 153-162. .
Paget SA, Zuniga-Montes RL, Markenson JA and Bateman H. Heel Pain in the Setting of Metabolic, Infiltrative, and Bone Disorders. In Disorders of the Heel, Rearfoot and Ankle. Eds. C. Ranawat and R. Positano. Philadelphia, PA: Churchill Livingstone, 1999, pp 172-179.
Paget S.A., Bateman, H. Markenson, J.A., and Zuniga-Motes, L.R. Heel Pain and Achilles Pain Associated with Rheumatoid Arthritis and Seronegative Spondyloarthropathies. In Disorders of the Heel, Rearfoot, and Ankle. Eds. C. Ranawat and R. Positano Churchill Livingstone Philadelphia Pa. 1999 pp180-187
Markenson JA. Psoriatic Arthritis in Manual of Rheumatology and Outpatient Orthopedic Disorders. Eds. S.A. Paget, A. Gibofsky, and John F. Berry III. Philadelphia, PA: Lippincott, Williams & Wilkins, 2000, pg. 279.
Markenson J.A. Guest Editor Rheumatic Disease Clinic of North America. Rheumatologic Manifestations of Endocrine Disease. Elsevier Volume 36,4,2010
Markenson, J.A.,Using the new biologic therapies in rheumatoid arthritis: practical aspects. Future Rheumatol 2(5), 475-483,2007
Markenson, J.A. Rheumatic Manifestations of endocrine diseases: Curr Opin Rheum 22:64-71,2010
Gibofsky, A., W.R.Palmer, E.C.Keystone., et al Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the Radius 1 and Radius 2 Registries. J. Rheum. 2011 38(1) 21-28
Markenson, J.A.,A.G.Gibofsky,Palmer,W.R., et al Persistence with Anti-Tumor Necrosis Factor Therapies in Patients with Rheumatoid Arthritis: Observation from the RADIUS Registry. J.Rheum. 2011, 38(7) 1273-1281
Chakravarty,S.,D, and J.A.Markenson: Rheumatic Manifestations of Endocrine Disease: Curr Opin Rheum 2013,25:37-43
Markenson, J.A.,A.S.Koenig,Jing Yuan Feng, et al. Comparison of Physician and Patient Global Assessments Over Time in Patients With Rheumatoid Arthritis. A Retrospective Analysis From the RADIUS Cohort. JCR:2013, 19 (6): 314-323
Markenson, J.A. Commentary on Review: Glucosamine and chondroitin,alone or in combination,do not clinically improve knee or hip pain in osteoarthritis. ACP Journal Club 2011,154;(3) JC3-4
Markenson, J.A.,Charalambous,K.,Wiereck,C.,et al US Rheumatologists’ Attitudes,Practice Habits,Barriers, and Knowledge Gaps in Assessing and Monitoring Patients with Rheumatoid Arthritis according to Recent Recommendations. CE Measure. 2013:7:87-95
Genovese, MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443–50
Kremer JM, Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Int Med 2002;137:726–33.
Markenson J. New standards and methods of care for treating the arthritic patient. J Muscoskel Med 2001;18:S1–S56
Pincus T, Koch GG, Sokka T, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587–98.
Bathon, J.M., Martin R.W., Fleischmann,R.M., Tesser, J.R., Schiff, M.H., Keystyone, E.C., Genovese, M.C., Moreland, L.M., Weaver, A.l., Markenson, J.M. and B.K. Finck. A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis. N.E.J.M.343:1586-1593,2000
Dr. Joseph Markenson is the principal investigator for drug studies involving patients with Rheumatic Diseases (Rheumatoid Arthritis, Osteoarthritis and Lupus). Ongoing recruitment for enrollment in studies currently active. Patients interested in more information or to participate in a Clinical Drug Trial should call his office at 212.606.1261.
Clinical Trials on therapeutics for the rheumatic diseases
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Markenson as of November 19, 2021.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.